Cancer Research UK has created a new base of operations for its staff in clinical research jobs in Oxford.
The new Oxford Cancer Research Centre has been established in partnership with the University of Oxford and the Oxford Radcliffe Hospitals NHS Trust and will be used to study several cancer types, including breast, skin, urological and gastrointestinal.
It will operate on a collaborative model and is set to focus on the molecular, genetic and lifestyle factors that influence cancer, as well as studies into biomarkers and diagnostic innovations.
The centre is already being used to conduct a clinical trial called Foxfire, which is evaluating a promising new form of internal radiotherapy called radio-embolisation.
Harpal Kumar, chief executive of Cancer Research UK, said: "Funding these centres of excellence is one of the charity's priorities and will enable us to work towards the goals we have set to improve the treatment and survival of cancer patients."
Earlier this week, the charity's Cancer Research Technology division allied with the Institute of Cancer Research and ZoBio to develop cancer therapies based on a new DNA target.